These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25518708)

  • 1. B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis.
    Yilmaz V; Oflazer P; Aysal F; Parman YG; Direskeneli H; Deymeer F; Saruhan-Direskeneli G
    Autoimmunity; 2015 Jun; 48(4):201-7. PubMed ID: 25518708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
    Front Immunol; 2020; 11():809. PubMed ID: 32508812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
    Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
    Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of miR-146a in myasthenia gravis.
    Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J
    Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).
    Çebi M; Durmuş H; Yılmaz V; Yentür SP; Aysal F; Oflazer P; Parman Y; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2019 Aug; 197(2):214-221. PubMed ID: 30929252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
    Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
    Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.
    Poussin MA; Goluszko E; Hughes TK; Duchicella SI; Christadoss P
    J Neuroimmunol; 2000 Nov; 111(1-2):152-60. PubMed ID: 11063833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
    Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T
    Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Nov; 141(10):3361-9. PubMed ID: 2972772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.
    Yi JS; Guidon A; Sparks S; Osborne R; Juel VC; Massey JM; Sanders DB; Weinhold KJ; Guptill JT
    J Autoimmun; 2014 Aug; 52():130-8. PubMed ID: 24378287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis.
    Matusevicius D; Navikas V; Palasik W; Pirskanen R; Fredrikson S; Link H
    J Neuroimmunol; 1996 Dec; 71(1-2):191-8. PubMed ID: 8982119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
    Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
    Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.